Sanofi to shutter PA R&D site, cut 400 jobs

Sanofi-Aventis will close its Great Valley, PA, research and development site by July 2011, with the exception of clinical supply and related support activities, in a move that will result in the loss of 400-plus jobs there. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.